Milestone Pharmaceuticals Inc. Share Price
NASDAQ: MIST | Micro CapMilestone Pharmaceuticals Inc. Stock Performance
Milestone Pharmaceuticals Inc. Share Price Today
As of 29 October 2026, Milestone Pharmaceuticals Inc.'s share price is $0.78. The stock opened at $0.78, compared to its previous close of $0.77. During today's trading session, Milestone Pharmaceuticals Inc.'s share price traded between $0.78 and $0.78, with an average price of $0.78. Over the past 52 weeks, the stock has recorded a high of $3.05 and a low of $0.63. In terms of performance, Milestone Pharmaceuticals Inc.'s share price has declined by 56.48% over the last six months and is down 59.30% on a year-on-year basis.
Milestone Pharmaceuticals Inc. Share Price Chart
Milestone Pharmaceuticals Inc. Quarterly Profit & Loss
All figures in USD
Milestone Pharmaceuticals Inc. Annual Profit & Loss
All figures in USD
About Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.
Milestone Pharmaceuticals Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $0.87 | $0.78 | -11.10% |
Sep 2026 | $1.15 | $0.87 | -26.55% |
Aug 2026 | $1.08 | $1.19 | +7.69% |
Jul 2026 | $1.35 | $1.10 | -17.54% |
Jun 2026 | $1.39 | $1.34 | -5.96% |
May 2026 | $1.79 | $1.43 | -20.83% |
Apr 2026 | $1.24 | $1.80 | +50.00% |
Mar 2026 | $1.69 | $1.20 | -30.03% |
Feb 2026 | $1.93 | $1.72 | -10.68% |
Jan 2026 | $2.05 | $1.92 | -5.19% |
Dec 2025 | $2.68 | $2.02 | -24.30% |
Nov 2025 | $1.95 | $2.67 | +38.96% |